NASDAQ: GMVDG Medical Innovations Holdings Ltd Stock
$2.69+0.78 (+40.84%)
Updated Mar 29, 2023
GMVD Price
$2.69
Fair Value Price
N/A
Market Cap
$1.87M
52 Week Low
$1.66
52 Week High
$57.05
P/E
0x
P/B
-0.45x
P/S
1.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.36M
Earnings
$32.47M
Gross Margin
-104.6%
Operating Margin
989.72%
Profit Margin
745.3%
Debt to Equity
-2.75
Operating Cash Flow
-$27M
Beta
0.11
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
GMVD Overview
G Medical Innovations Holdings Ltd. offers mobile health and telemedicine solutions in the U.S, China, and Israel. Offerings include the Prizma health monitor, the Extended Holter Patch System, and the Wireless Vital Signs Monitoring System. It also offers monitoring services to independent diagnostic testing facilities. G Medical was incorporated in 2014 and is based in Rehovot, Israel.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GMVD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GMVD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GMVD is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
GMVD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more GMVD due diligence checks available for Premium users.
Be the first to know about important GMVD news, forecast changes, insider trades & much more!
GMVD News
Valuation
GMVD fair value
Fair Value of GMVD stock based on Discounted Cash Flow (DCF)
Price
$2.69
Fair Value
$2.14
Overvalued by
25.92%
GMVD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
GMVD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
23.66x
Market
21.81x
GMVD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.45x
Industry
3.5x
GMVD's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
GMVD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
GMVD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$10.3M
Liabilities
$11.5M
Debt to equity
-2.75
GMVD's short-term liabilities ($10.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GMVD's short-term assets ($5.92M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GMVD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GMVD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
GMVD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
GMVD vs Medical Stocks
G Medical Innovations Holdings Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.